[Resistance of Shigella sonnei against chemotherapeutic agents with special reference to R-factor-induced resistance and to colicin typing].
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002509:Cephaloridine / Q000494:pharmacology; D002512:Cephalothin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003087:Colicins; D004269:DNA, Bacterial; D004926:Escherichia coli; D005111:Extrachromosomal Inheritance; D008826:Microbial Sensitivity Tests; D009355:Neomycin / Q000494:pharmacology; D010403:Penicillin Resistance; D012703:Serotyping; D012764:Shigella sonnei / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D003087:Colicins; D004269:DNA, Bacterial; D013449:Sulfonamides; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D009355:Neomycin; D002509:Cephaloridine; D002512:Cephalothin; D013307:Streptomycin
Die Resistenz von Shigella sonnei gegen Chemotherapeutika mit besonderer Berücksichtighung der R-Faktor-bewirkten Resistenz und der Colicin-Typisierung.